Rhythm Pharmaceuticals (RYTM) Preferred Dividend Payments (2024 - 2026)

Rhythm Pharmaceuticals (RYTM) has 3 years of Preferred Dividend Payments data on file, last reported at $1.1 million in Q1 2026.

• On a quarterly basis, Preferred Dividend Payments fell 16.49% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $5.2 million, a 2.49% decrease from a year earlier, with the FY2025 full-year figure at $5.4 million, up 35.47% from the prior year.
• Preferred Dividend Payments for Q1 2026 stood at $1.1 million, down from $1.3 million in the prior quarter.
• Over the last five years, Preferred Dividend Payments for RYTM reached as high as $1.4 million in Q3 2025 and fell as low as $1.1 million in Q1 2026.
• Historically, Preferred Dividend Payments has averaged $1.3 million across 3 years, with a median of $1.3 million in 2024.
• Across the five-year window, Preferred Dividend Payments advanced 3.61% in 2025 and dropped 16.49% in 2026, its largest moves.
• Year by year, Preferred Dividend Payments stood at $1.3 million in 2024, then slipped by 0.52% to $1.3 million in 2025, then decreased by 17.12% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Preferred Dividend Payments figures were $1.1 million in Q1 2026, $1.3 million in Q4 2025, and $1.4 million in Q3 2025.